116 related articles for article (PubMed ID: 8018950)
1. Competitive repopulation in leukemic and normal bone marrow.
Brecher G; Pallavicini MG; Cronkite EP
Blood Cells; 1993; 19(3):691-7; discussion 698-707. PubMed ID: 8018950
[TBL] [Abstract][Full Text] [Related]
2. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
3. Autologous transplant for CML revisited.
Daley GQ; Goldman JM
Exp Hematol; 1993 Jun; 21(6):734-7. PubMed ID: 8500574
[TBL] [Abstract][Full Text] [Related]
4. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L
Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986
[TBL] [Abstract][Full Text] [Related]
5. [In-vitro change in CFU-GM in chronic myeloid leukemia and myelodysplastic syndromes. Its implication in the dysfunction of the hematologic barrier].
Gronda M; Malka A; Demattei A; Elizalde P; Santarelli MT; Bianchi de Di Risio CC
Sangre (Barc); 1988 Aug; 33(4):277-81. PubMed ID: 3187844
[No Abstract] [Full Text] [Related]
6. Effect of a transplantable leukemia on hematopoietic stem cells in AKR mice.
Nakeff A; Valeriote FA
Cancer Treat Rep; 1978 May; 62(5):737-41. PubMed ID: 657159
[TBL] [Abstract][Full Text] [Related]
7. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF
Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115
[TBL] [Abstract][Full Text] [Related]
8. Effect of cryopreservation on purging of leukemic marrow with alkyl-lysophospholipids.
Vogler WR; Somberg LB; Glasser L
Exp Hematol; 1987 May; 15(4):360-4. PubMed ID: 3569439
[TBL] [Abstract][Full Text] [Related]
9. Difficulties in collecting peripheral blood stem cells in chronic myeloid leukemia related to persistence of the leukemic cell clone.
Hénon PR; Eisenmann JC; Becker M; Beck-Wirth G; Wunder E; Sovalat H
Stem Cells; 1993 Oct; 11 Suppl 3():43-7. PubMed ID: 8298478
[TBL] [Abstract][Full Text] [Related]
10. Relapse after allogeneic BMT for chronic myeloid leukemia (CML) may be sustained by a small number of leukemic 'stem cells': a hypothesis.
Frassoni F; Podestà M; Piaggio G; Pitto A; Figari O; Soracco M; Lint M; Fugazza G; Sessarego M; Bacigalupo A
Bone Marrow Transplant; 1999 Sep; 24(6):689-91. PubMed ID: 10490738
[TBL] [Abstract][Full Text] [Related]
11. Prolonged remission and autologous recovery in two patients with chronic myelogenous leukemia after graft failure of allogeneic bone marrow transplantation.
Fouillard L; Deconinck E; Tiberghien P; Deschaseaux ML; Solary E; Mugneret F; Brion A; Herve P; Cahn JY
Bone Marrow Transplant; 1998 May; 21(9):943-6. PubMed ID: 9613789
[TBL] [Abstract][Full Text] [Related]
12. [Primary myelodysplastic syndromes].
Brohée D
Rev Med Brux; 1988 Sep; 9(6):327-33. PubMed ID: 3051250
[No Abstract] [Full Text] [Related]
13. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.
Slavin S; Aker M; Shapira MY; Resnick I; Bitan M; Or R
Clin Transpl; 2003; ():275-82. PubMed ID: 15387119
[TBL] [Abstract][Full Text] [Related]
14. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
Kometani K; Aoki M; Kawamata S; Shinozuka Y; Era T; Taniwaki M; Hattori M; Minato N
Cancer Res; 2006 Oct; 66(20):9967-76. PubMed ID: 17047059
[TBL] [Abstract][Full Text] [Related]
15. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
[TBL] [Abstract][Full Text] [Related]
16. Autologous transplantation for chronic myelogenous leukemia with mafosfamide-treated marrow.
Rizzoli V; Mangoni L; Almici C; Caramatti C; Dotti GP; Carlo-Stella C
Stem Cells; 1993 Oct; 11 Suppl 3():25-30. PubMed ID: 8298474
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-2 activation of human bone marrow in long-term cultures: an effective strategy for purging and generation of anti-tumor cytotoxic effectors.
Verma UN; Bagg A; Brown E; Mazumder A
Bone Marrow Transplant; 1994 Feb; 13(2):115-23. PubMed ID: 8205079
[TBL] [Abstract][Full Text] [Related]
18. Characterization and selection of benign stem cells in chronic myeloid leukemia.
Lemoli RM
Haematologica; 1993; 78(6):393-400. PubMed ID: 8175034
[TBL] [Abstract][Full Text] [Related]
19. ABL oncogenes directly stimulate two distinct target cells in bone marrow from 5-fluorouracil-treated mice.
Kelliher MA; Weckstein DJ; Knott AG; Wortis HH; Rosenberg N
Oncogene; 1993 May; 8(5):1249-56. PubMed ID: 8479746
[TBL] [Abstract][Full Text] [Related]
20. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
Sawai N; Koike K; Ito S; Okumura N; Kamijo T; Shiohara M; Amano Y; Tsuji K; Nakahata T; Oda M
Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
